The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative studyE. Jane Macaskill, J. Michael Dixon, Vicky S. Sabine et al.|Breast Cancer Research and Treatment|2010Cited by 55